Alys Pharmaceuticals (private company)

See something wrong or missing? Let us know
Offices:Geneva
Business model:B2B

Alys Pharmaceuticals is the merger result of six of dermatology-focused companies by Medicxi, doing R&D anchored immuno-dermatology to redefine the treatment landscape, bringing transformative solutions to patients worldwide

Investors: we tracked 1 investor

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 100M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Alys Pharmaceuticals

Name Criteria
United Kingdom Beckley Psytech
58%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 10M+ USD
Denmark Cytoki Pharma
58%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 10M+ USD
Germany Abalos Therapeutics
58%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 10M+ USD
Germany Emergence Therapeutics
58%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 10M+ USD
France SafeHeal
58%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 10M+ USD
Belgium Precirix
58%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 10M+ USD
Italy Kither Biotech
58%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 10M+ USD
United Kingdom OMass Therapeutics
58%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 10M+ USD
Spain Minoryx
58%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 10M+ USD
France Qubit Pharmaceuticals
58%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 10M+ USD
Top